Abiraterone/niraparib Interactions
There are 876 drugs known to interact with abiraterone/niraparib, along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 134 are major, 667 are moderate, and 75 are minor.
- View all 876 medications that may interact with abiraterone/niraparib
- View abiraterone/niraparib alcohol/food interactions (2)
- View abiraterone/niraparib disease interactions (7)
Most frequently checked interactions
View interaction reports for abiraterone / niraparib and the medicines listed below.
- Align (bifidobacterium infantis)
- Atacand (candesartan)
- Ativan (lorazepam)
- Coenzyme Q10 (ubiquinone)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Ginkgo Biloba (ginkgo)
- Lupron (leuprolide)
- Mavik (trandolapril)
- Metoprolol Succinate ER (metoprolol)
- Myrbetriq (mirabegron)
- Nicotinamide Dietary Supplement (multivitamin with minerals)
- Nubeqa (darolutamide)
- Orgovyx (relugolix)
- Paracetamol (acetaminophen)
- PreserVision AREDS 2 (multivitamin with minerals)
- Quercetin (bioflavonoids)
- Rufen (ibuprofen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B2 (riboflavin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K1 (phytonadione)
- Vitamin K2 (menaquinone)
- Voltaren Arthritis Pain Gel (diclofenac topical)
Abiraterone/niraparib alcohol/food interactions
There are 2 alcohol/food interactions with abiraterone / niraparib.
Abiraterone/niraparib disease interactions
There are 7 disease interactions with abiraterone / niraparib which include:
- hepatic impairment
- CVD
- cardiovascular disorders
- liver dysfunction
- MDS/AML
- pancytopenia
- renal impairment
More about abiraterone / niraparib
- abiraterone/niraparib consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.